Journal
CLINICAL & TRANSLATIONAL ONCOLOGY
Volume 19, Issue 4, Pages 409-418Publisher
SPRINGER INTERNATIONAL PUBLISHING AG
DOI: 10.1007/s12094-016-1561-6
Keywords
Cancer; Warburg effect; Mitochondria; mtDNA; OXPHOS; ROS
Categories
Funding
- Instituto de Salud Carlos III [PI13/ 01806, PIE14/0064, PI10/0703, PI13/00556, PI04/1001]
- Comunidad Autonoma de Madrid [S2010/BMD-2402]
- Fundacion Mutua Madrilena [10.04.02.0064]
Ask authors/readers for more resources
The potential role of the mitochondrial genome has recently attracted interest because of its high mutation frequency in tumors. Different aspects of mtDNA make it relevant for cancer's biology, such as it encodes a limited but essential number of genes for OXPHOS biogenesis, it is particularly susceptible to mutations, and its copy number can vary. Moreover, most ROS in mitochondria are produced by the electron transport chain. These characteristics place the mtDNA in the center of multiple signaling pathways, known as mitochondrial retrograde signaling, which modifies numerous key processes in cancer. Cybrid studies support that mtDNA mutations are relevant and exert their effect through a modification of OXPHOS function and ROS production. However, there is still much controversy regarding the clinical relevance of mtDNA mutations. New studies should focus more on OXPHOS dysfunction associated with a specific mutational signature rather than the presence of mutations in the mtDNA.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available